Article Information
PubMed
Published By
History
- Received August 8, 2012
- Revision received January 31, 2013
- Accepted February 15, 2013
- First published April 10, 2013.
- Version of record published April 10, 2013.
Copyright & Usage
Copyright © 2013 the authors 0270-6474/13/336380-08$15.00/0
Author Information
- Emma K. Towlson1,
- Petra E. Vértes2,
- Sebastian E. Ahnert1,
- William R. Schafer3, and
- Edward T. Bullmore2,4,5
- 1Theory of Condensed Matter Group, Department of Physics, Cavendish Laboratory, University of Cambridge, Cambridge CB3 0HE, United Kingdom,
- 2Behavioural and Clinical Neuroscience Institute, Department of Psychiatry, University of Cambridge, Cambridge CB2 0SP, United Kingdom,
- 3Cell Biology Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom,
- 4Cambridgeshire and Peterborough National Health Service Foundation Trust, Cambridge CB21 5EF, United Kingdom, and
- 5GlaxoSmithKline, Clinical Unit Cambridge, Addenbrooke's Hospital, Cambridge CB2 0AA, United Kingdom
Author contributions
Author contributions: E.K.T., P.E.V., S.E.A., W.R.S., and E.T.B. designed research; E.K.T. performed research; E.K.T. analyzed data; E.K.T., S.E.A., and E.T.B. wrote the paper.
Disclosures
- Received August 8, 2012.
- Revision received January 31, 2013.
- Accepted February 15, 2013.
The Behavioural and Clinical Neuroscience Institute is supported by the Medical Research Council (United Kingdom) and the Wellcome Trust. E.K.T. is supported by an Engineering and Physical Sciences Research Council (United Kingdom) doctoral studentship. S.E.A. is supported by the Royal Society (United Kingdom).
E.T.B. is employed half-time by the University of Cambridge and half-time by GlaxoSmithKline and holds stock in GlaxoSmithKline. The remaining authors declare no competing financial interests.
- Correspondence should be addressed to Emma Towlson, TCM Group, Cavendish Laboratory, J.J. Thomson Avenue, Cambridge CB3 0HE, United Kingdom. ekt33{at}cam.ac.uk
